These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11071642)

  • 1. Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor-related protein.
    Neels JG; van Den Berg BM; Mertens K; ter Maat H; Pannekoek H; van Zonneveld AJ; Lenting PJ
    Blood; 2000 Nov; 96(10):3459-65. PubMed ID: 11071642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residues Phe342-Asn346 of activated coagulation factor IX contribute to the interaction with low density lipoprotein receptor-related protein.
    Rohlena J; Kolkman JA; Boertjes RC; Mertens K; Lenting PJ
    J Biol Chem; 2003 Mar; 278(11):9394-401. PubMed ID: 12522212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
    Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
    J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII.
    Bovenschen N; Boertjes RC; van Stempvoort G; Voorberg J; Lenting PJ; Meijer AB; Mertens K
    J Biol Chem; 2003 Mar; 278(11):9370-7. PubMed ID: 12522143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subpopulation of platelets responds to thrombin- or SFLLRN-stimulation with binding sites for factor IXa.
    London FS; Marcinkiewicz M; Walsh PN
    J Biol Chem; 2004 May; 279(19):19854-9. PubMed ID: 15010476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
    Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
    J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans.
    Kounnas MZ; Chappell DA; Wong H; Argraves WS; Strickland DK
    J Biol Chem; 1995 Apr; 270(16):9307-12. PubMed ID: 7721852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor IX activation by factor XIa proceeds without release of a free intermediate.
    Wolberg AS; Morris DP; Stafford DW
    Biochemistry; 1997 Apr; 36(14):4074-9. PubMed ID: 9100000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, alpha2-macroglobulin, factor IXa and factor VIII.
    Meijer AB; Rohlena J; van der Zwaan C; van Zonneveld AJ; Boertjes RC; Lenting PJ; Mertens K
    Biochim Biophys Acta; 2007 Jun; 1774(6):714-22. PubMed ID: 17512806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zymogen factor IX potentiates factor IXa-catalyzed factor X activation.
    London FS; Walsh PN
    Biochemistry; 2000 Aug; 39(32):9850-8. PubMed ID: 10933803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baculovirus-mediated expression of the epidermal growth factor-like modules of human factor IX fused to the factor XIIIa transamidation site in fibronectin. Evidence for a direct interaction between the NH2-terminal epidermal growth factor-like module of factor IXa beta and factor X.
    Astermark J; Sottile J; Mosher DF; Stenflo J
    J Biol Chem; 1994 Feb; 269(5):3690-7. PubMed ID: 7906269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of ligand binding to the second cluster of complement-type repeats of the low density lipoprotein receptor-related protein. Evidence for an allosteric component in receptor-associated protein-mediated inhibition of ligand binding.
    Horn IR; van den Berg BM; van der Meijden PZ; Pannekoek H; van Zonneveld AJ
    J Biol Chem; 1997 May; 272(21):13608-13. PubMed ID: 9153209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
    Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
    Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
    Ahmad SS; Walsh PN
    Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha -chains of C4b-binding protein mediate complex formation with low density lipoprotein receptor-related protein.
    Westein E; Denis CV; Bouma BN; Lenting PJ
    J Biol Chem; 2002 Jan; 277(4):2511-6. PubMed ID: 11705989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein.
    Mikhailenko I; Krylov D; Argraves KM; Roberts DD; Liau G; Strickland DK
    J Biol Chem; 1997 Mar; 272(10):6784-91. PubMed ID: 9045712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain.
    McCord DM; Monroe DM; Smith KJ; Roberts HR
    J Biol Chem; 1990 Jun; 265(18):10250-4. PubMed ID: 2355000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.
    Lenting PJ; van de Loo JW; Donath MJ; van Mourik JA; Mertens K
    J Biol Chem; 1996 Jan; 271(4):1935-40. PubMed ID: 8567641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa.
    Larson PJ; Stanfield-Oakley SA; VanDusen WJ; Kasper CK; Smith KJ; Monroe DM; High KA
    J Biol Chem; 1996 Feb; 271(7):3869-76. PubMed ID: 8632006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
    Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
    Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.